Cargando…
If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma
BACKGROUND: Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification affecting therapeutic strategies for NHL patients. BM immunophenotyping by fl...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995803/ https://www.ncbi.nlm.nih.gov/pubmed/21106070 http://dx.doi.org/10.1186/1471-2407-10-644 |
_version_ | 1782193115478622208 |
---|---|
author | Mancuso, Patrizia Calleri, Angelica Antoniotti, Pierluigi Quarna, Jessica Pruneri, Giancarlo Bertolini, Francesco |
author_facet | Mancuso, Patrizia Calleri, Angelica Antoniotti, Pierluigi Quarna, Jessica Pruneri, Giancarlo Bertolini, Francesco |
author_sort | Mancuso, Patrizia |
collection | PubMed |
description | BACKGROUND: Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification affecting therapeutic strategies for NHL patients. BM immunophenotyping by flow cytometry (FC) is also used, although its clinical value is still under debate. METHODS: Using FC we analyzed 1,000 paired BM aspirates and peripheral blood (PB) samples from 591 NHL patients to investigate the concordance between BM and PB. B-lymphocytes were defined monoclonal when a ratio of 0.3 < κ/l > 3 was observed. Aberrant immunophenotypes present in the B-cell subpopulation were also investigated. BM-TB was also performed in 84.1% of samples (841/1000), and concordance between BM-TB and BM-FC was evaluated. Concordance was defined as the presence of a positive (in terms of disease detection) or negative result in both BM-FC and PB-FC or BM-TB and BM-FC. RESULTS: Using FC, the overall concordance between BM and PB was 95%. Among the discordant cases (ie presence of neoplastic B-lymphocyte in the BM but under the sensibility of the technique in the PB) the most frequent diagnosis was Waldenstrom's macroglobulinemia (WM, accounting for 20.8% of all discordant cases). The expression of CXCR4, a receptor involved in B-cell trafficking and homing, was found to be down regulated in WM compared to other NHL types, thus suggesting a possible role of CXCR4 in WM cell homing in the BM. WM excluded, FC investigation of BM and PB in NHL patients gives overlapping information. BM involvement was observed by FC in 38% of samples, and concordance between BM-FC and BM-TB was 85%. CONCLUSIONS: The finding that FC data from BM and PB samples overlap in NHL might have major implications for the design of future clinical studies and for patients' follow-up. |
format | Text |
id | pubmed-2995803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29958032010-12-02 If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma Mancuso, Patrizia Calleri, Angelica Antoniotti, Pierluigi Quarna, Jessica Pruneri, Giancarlo Bertolini, Francesco BMC Cancer Research Article BACKGROUND: Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification affecting therapeutic strategies for NHL patients. BM immunophenotyping by flow cytometry (FC) is also used, although its clinical value is still under debate. METHODS: Using FC we analyzed 1,000 paired BM aspirates and peripheral blood (PB) samples from 591 NHL patients to investigate the concordance between BM and PB. B-lymphocytes were defined monoclonal when a ratio of 0.3 < κ/l > 3 was observed. Aberrant immunophenotypes present in the B-cell subpopulation were also investigated. BM-TB was also performed in 84.1% of samples (841/1000), and concordance between BM-TB and BM-FC was evaluated. Concordance was defined as the presence of a positive (in terms of disease detection) or negative result in both BM-FC and PB-FC or BM-TB and BM-FC. RESULTS: Using FC, the overall concordance between BM and PB was 95%. Among the discordant cases (ie presence of neoplastic B-lymphocyte in the BM but under the sensibility of the technique in the PB) the most frequent diagnosis was Waldenstrom's macroglobulinemia (WM, accounting for 20.8% of all discordant cases). The expression of CXCR4, a receptor involved in B-cell trafficking and homing, was found to be down regulated in WM compared to other NHL types, thus suggesting a possible role of CXCR4 in WM cell homing in the BM. WM excluded, FC investigation of BM and PB in NHL patients gives overlapping information. BM involvement was observed by FC in 38% of samples, and concordance between BM-FC and BM-TB was 85%. CONCLUSIONS: The finding that FC data from BM and PB samples overlap in NHL might have major implications for the design of future clinical studies and for patients' follow-up. BioMed Central 2010-11-24 /pmc/articles/PMC2995803/ /pubmed/21106070 http://dx.doi.org/10.1186/1471-2407-10-644 Text en Copyright ©2010 Mancuso et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mancuso, Patrizia Calleri, Angelica Antoniotti, Pierluigi Quarna, Jessica Pruneri, Giancarlo Bertolini, Francesco If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title | If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title_full | If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title_fullStr | If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title_full_unstemmed | If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title_short | If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma |
title_sort | if it is in the marrow, is it also in the blood? an analysis of 1,000 paired samples from patients with b-cell non-hodgkin lymphoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995803/ https://www.ncbi.nlm.nih.gov/pubmed/21106070 http://dx.doi.org/10.1186/1471-2407-10-644 |
work_keys_str_mv | AT mancusopatrizia ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma AT calleriangelica ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma AT antoniottipierluigi ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma AT quarnajessica ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma AT prunerigiancarlo ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma AT bertolinifrancesco ifitisinthemarrowisitalsointhebloodananalysisof1000pairedsamplesfrompatientswithbcellnonhodgkinlymphoma |